Interesting update, retatrutide shows ~30% weight loss with metabolic benefits, highlighting its potential as a next-generation obesity therapy.
The most common symptoms, which are mild and temporary, include abdominal pain, loose stools, and increased flatulence (mostly associated with oral supplementation)
In light of these challenges, in this study, we assess the impact of GLP-1 and its derivatives on pain behavior and their influence on the peripheral nervous system
Regular sessions are recommended to maintain optimal nutrient levels and sustained health benefits
Semaglutide had consistent beneficial effects on all secondary efficacy endpoints (including six-minute walk distance) across diuretic subgroups (p interaction=0.24-0.92)
In the brain, it acts on appetite centers to reduce hunger and food intake, which significantly contributes to weight loss